Search the site

News & Events

Come along to our first ever Science & Sip for teachers

Want to find out more about what an excursion to The Kids is all about? Join us for our first ever Science & Sip!

News & Events

Pre-term kids get green light to exercise

Parents of children born prematurely have expressed concerns about their child’s lung health when they exercise, with symptoms such as breathlessness.

News & Events

New funding to accelerate AI personalised phage therapies

Wal-yan researchers have been awarded $500,000 for their innovative research, supported by the Western Australian Government’s Future Health Medical Research and Innovation (FHRI) Fund.

Phage therapy a CF ‘game changer’

Cutting-edge work is offering new hope to children with Cystic Fibrosis.

News & Events

Bushfires: Tips to protect family from smoke exposure

Perth’s north-east is under threat from an out-of-control bushfire.

News & Events

Toxic, harmful chemicals found in popular Australian e-liquids

Perth researchers have found toxic and harmful chemicals in several dozen e-cigarette liquids readily available in Australia.

News & Events

Congratulations Andrew

Congratulations to Professor Andrew Whitehouse on being named a finalist in the prestigious Premier’s Science Awards.

News & Events

Enhancing the lung health for preterm birth survivors by uncovering treatable traits

A project to uncover treatable traits to improve the lung health of people born preterm has been made possible thanks to a $1.99 million Medical Research Future Fund (MRFF) grant.

News & Events

Community partnership sets priorities for preterm lung health research

Respiratory disease remains one of the most significant complications of preterm birth, with lasting consequences.

Research

SHIP CT: A Phase 3 randomised, double-blind, controlled trial of inhaled 7% hypertonic saline versus 0.9% isotonic saline for 48 weeks in patients with Cystic Fibrosis at 3-6 years of age in parallel with the North American SHIP clinical trial.

SHIP-CT, led by Professor Stephen Stick, Director of the Wal-yan Respiratory Research Centre at The Kids, is a unique study in preschool-aged children (from 3-6 years of age) with CF using images of the lung from chest CT scans as the main outcome measure.